Previous reports have shown that restoration of dystrophin expression at levels equivalent to just 20% of healthy individuals has been sufficient to prevent symptoms of DMD, suggesting that our ASOs are promising preclinical candidates38,39. Here, DMD is linked to Duchenne muscular dystrophy.